Bristol-Myers Squibb: Drugs Sales & Forecast

S.No.	Company Name	Short Description	No of Drugs	Company Drug Price	Action
1	Bristol-Myers Squibb	Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV and AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.	6	75.00	BUY	Your Query

S.No.	Updated On	Drug	Price in USD	Action
1	Jun, 2020	Baraclude Drug Sales & Forecast BMS drug Baraclude was first approved in March 2005 and subsequent approvals in Japan and the five major EU markets (France, Germany, Italy, Spain, and th....	15.00	READ	BUY	Your Query
2	Jun, 2020	Eliquis Drug Sales & Forecast BMS drug Eliquis (apixaban) is an oral Factor Xa inhibitor, targeted at stroke prevention in adult patients with NVAF and the prevention and treatment of ....	15.00	READ	BUY	Your Query
3	Jun, 2020	Empliciti Drug Sales & Forecast BMS and AbbVie jointly develop and commercialize Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma. Both parties participat....	15.00	READ	BUY	Your Query
4	Jun, 2020	Opdivo/Yervoy Drug Sales & Forecast Opdivo is a programmed death-1 (PD-1) immune checkpoint inhibitor that is designed to uniquely harness the body’s own immune system to help restore anti....	15.00	READ	BUY	Your Query
5	Jun, 2020	Orencia Drug Sales & Forecast BMS drug Orencia (abatacept), a biological product, is a fusion protein indicated for adult patients with moderately to severely active rheumatoid arthrit....	15.00	READ	BUY	Your Query
6	Jun, 2020	Sprycel Drug Sales & Forecast BMS drug Sprycel (dasatinib) is an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromos....	15.00	READ	BUY	Your Query

Useful Links